As I understand it, the cost for the first product will be booked to revenue (and most likely cashflow) this half - it is just the profit share that doesn't get booked as revenue until 1H18? So there should at least be a bit of an indication in the next report as to what the product is worth.
Ann: Generics Sales Update, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.66M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $16.34K | 145.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 201538 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30651 | 1 |
View Market Depth
| Last trade - 15.49pm 21/06/2024 (20 minute delay) ? |
| IDT (ASX) Chart |